Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
81
CPRX Quote, Financials, Valuation and Earnings
Last price:
$24.43
Seasonality move
:
6.75%
Day range:
$24.19 - $24.45
52-week range:
$19.05 - $26.58
Dividend yield:
0%
P/E ratio:
14.27x
P/S ratio:
5.37x
P/B ratio:
3.27x
Volume:
513.5K
Avg. volume:
1.3M
1-year change:
13.09%
Market cap:
$3B
Revenue:
$491.7M
EPS (TTM):
$1.71
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $119.1M | $140.8M | $214.2M | $398.2M | $491.7M | |
| Revenue Growth (YoY) | 16.39% | 18.28% | 52.1% | 85.9% | 23.49% | |
| Cost of Revenues | $17M | $21.9M | $34.4M | $84.5M | $106.2M | |
| Gross Profit | $102M | $118.9M | $179.8M | $313.7M | $385.5M | |
| Gross Profit Margin | 85.69% | 84.46% | 83.94% | 78.77% | 78.4% | |
| R&D Expenses | $16.5M | $16.9M | $19.8M | $93.2M | $12.6M | |
| Selling, General & Admin | $44.2M | $45.2M | $52M | $120.9M | $157.3M | |
| Other Inc / (Exp) | $587K | $282K | $2.9M | $3M | $5.1M | |
| Operating Expenses | $60.7M | $66.6M | $78M | $226.9M | $190.4M | |
| Operating Income | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $41.9M | $52.7M | $104.7M | $94.5M | $216.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$33.1M | $13.2M | $21.6M | $23.1M | $52.4M | |
| Net Income to Company | $75M | $39.5M | $83.1M | $71.4M | $163.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $75M | $39.5M | $83.1M | $71.4M | $163.9M | |
| Basic EPS (Cont. Ops) | $0.72 | $0.38 | $0.80 | $0.67 | $1.38 | |
| Diluted EPS (Cont. Ops) | $0.71 | $0.37 | $0.75 | $0.63 | $1.31 | |
| Weighted Average Basic Share | $103.5M | $103.4M | $103.4M | $106.3M | $118.5M | |
| Weighted Average Diluted Share | $106.2M | $107.8M | $111.4M | $113.8M | $124.9M | |
| EBITDA | $41.4M | $52.9M | $103.3M | $120M | $233.2M | |
| EBIT | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Revenue (Reported) | $119.1M | $140.8M | $214.2M | $398.2M | $491.7M | |
| Operating Income (Reported) | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Operating Income (Adjusted) | $41.3M | $52.4M | $101.8M | $86.8M | $195.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $36M | $57.2M | $102.7M | $128.7M | $148.4M | |
| Revenue Growth (YoY) | 22.64% | 59.22% | 79.39% | 25.33% | 15.31% | |
| Cost of Revenues | $5.3M | $9.7M | $22.7M | $28.6M | $32M | |
| Gross Profit | $30.6M | $47.6M | $80M | $100.1M | $116.4M | |
| Gross Profit Margin | 85.23% | 83.12% | 77.94% | 77.76% | 78.44% | |
| R&D Expenses | $4.5M | $8.3M | $83.7M | $3.3M | $2.7M | |
| Selling, General & Admin | $11.1M | $12.6M | $30.1M | $41.9M | $42.2M | |
| Other Inc / (Exp) | $68K | $905K | -$568K | $1.8M | -- | |
| Operating Expenses | $16.6M | $22.5M | $117.2M | $49.2M | $50.1M | |
| Operating Income | $14M | $25.1M | -$37.2M | $50.9M | $66.3M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14.1M | $26M | -$38M | $57.2M | $71M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $3.7M | $3.3M | -$7.3M | $13.3M | $18.3M | |
| Net Income to Company | $10.3M | $22.7M | -$30.8M | $43.9M | $52.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $10.3M | $22.7M | -$30.8M | $43.9M | $52.8M | |
| Basic EPS (Cont. Ops) | $0.10 | $0.22 | -$0.29 | $0.37 | $0.43 | |
| Diluted EPS (Cont. Ops) | $0.10 | $0.20 | -$0.29 | $0.35 | $0.42 | |
| Weighted Average Basic Share | $103.2M | $103.3M | $106.6M | $118.9M | $122.6M | |
| Weighted Average Diluted Share | $107.8M | $112M | $106.6M | $125.4M | $127.1M | |
| EBITDA | $14.1M | $25.7M | -$28.6M | $60.4M | $75.7M | |
| EBIT | $14M | $25.1M | -$37.2M | $50.9M | $66.3M | |
| Revenue (Reported) | $36M | $57.2M | $102.7M | $128.7M | $148.4M | |
| Operating Income (Reported) | $14M | $25.1M | -$37.2M | $50.9M | $66.3M | |
| Operating Income (Adjusted) | $14M | $25.1M | -$37.2M | $50.9M | $66.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $133.5M | $191.8M | $348.4M | $460.5M | $578.2M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $19.4M | $30.5M | $70.9M | $100.1M | $120.2M | |
| Gross Profit | $114.1M | $161.2M | $277.5M | $360.4M | $458M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $16.1M | $20.7M | $95.3M | $10.8M | $14.7M | |
| Selling, General & Admin | $45.2M | $51M | $95.9M | $156M | $162.4M | |
| Other Inc / (Exp) | $317K | $745K | $3.3M | $1.9M | -- | |
| Operating Expenses | $65.9M | $77.4M | $201.6M | $186.4M | $199.2M | |
| Operating Income | $48.3M | $83.8M | $75.9M | $174M | $258.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $48.6M | $84.5M | $80.8M | $188.8M | $285.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7M | $17.6M | $18.8M | $46M | $68.2M | |
| Net Income to Company | $41.6M | $66.9M | $62M | $142.8M | $217.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $41.6M | $66.9M | $62M | $142.8M | $217.6M | |
| Basic EPS (Cont. Ops) | $0.40 | $0.65 | $0.59 | $1.24 | $1.79 | |
| Diluted EPS (Cont. Ops) | $0.39 | $0.61 | $0.53 | $1.17 | $1.71 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $48.7M | $84.7M | $100.5M | $211.6M | $296.6M | |
| EBIT | $48.3M | $83.8M | $75.9M | $174M | $258.8M | |
| Revenue (Reported) | $133.5M | $191.8M | $348.4M | $460.5M | $578.2M | |
| Operating Income (Reported) | $48.3M | $83.8M | $75.9M | $174M | $258.8M | |
| Operating Income (Adjusted) | $48.3M | $83.8M | $75.9M | $174M | $258.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $102.5M | $153.4M | $287.6M | $349.9M | $436.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $14.5M | $23.2M | $59.7M | $75.2M | $89.2M | |
| Gross Profit | $88M | $130.2M | $228M | $274.7M | $347.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $11.9M | $15.7M | $91.2M | $8.9M | $10.9M | |
| Selling, General & Admin | $35.3M | $38.8M | $82.7M | $117.8M | $123M | |
| Other Inc / (Exp) | $211K | $674K | $1.1M | -$1.6M | -$308K | |
| Operating Expenses | $48.3M | $59.2M | $182.9M | $142.4M | $151.2M | |
| Operating Income | $39.6M | $71M | $45.1M | $132.3M | $195.9M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $39.9M | $71.7M | $47.8M | $142.1M | $211.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $9.7M | $14.1M | $11.2M | $34.1M | $50M | |
| Net Income to Company | $30.2M | $57.6M | $36.6M | $108M | $161.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $30.2M | $57.6M | $36.6M | $108M | $161.6M | |
| Basic EPS (Cont. Ops) | $0.29 | $0.56 | $0.35 | $0.91 | $1.32 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.52 | $0.30 | $0.87 | $1.27 | |
| Weighted Average Basic Share | $310.4M | $308.9M | $318.4M | $353.9M | $366.2M | |
| Weighted Average Diluted Share | $322.3M | $330.3M | $334.2M | $373.5M | $381.6M | |
| EBITDA | $39.9M | $71.8M | $69.1M | $160.8M | $224.3M | |
| EBIT | $39.6M | $71M | $45.1M | $132.3M | $195.9M | |
| Revenue (Reported) | $102.5M | $153.4M | $287.6M | $349.9M | $436.4M | |
| Operating Income (Reported) | $39.6M | $71M | $45.1M | $132.3M | $195.9M | |
| Operating Income (Adjusted) | $39.6M | $71M | $45.1M | $132.3M | $195.9M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $130.2M | $191.3M | $298.4M | $137.6M | $517.6M | |
| Short Term Investments | $10M | $19.8M | -- | -- | -- | |
| Accounts Receivable, Net | $6M | $6.6M | $10.4M | $53.5M | $65.5M | |
| Inventory | $4.7M | $7.9M | $6.8M | $15.6M | $19.5M | |
| Prepaid Expenses | $7.4M | $3.9M | $4.2M | $12M | $20M | |
| Other Current Assets | $883K | $327K | -- | $351K | $1M | |
| Total Current Assets | $159.2M | $210.1M | $320.8M | $219.3M | $623.6M | |
| Property Plant And Equipment | $130K | $4M | $3.6M | $3.7M | $3.6M | |
| Long-Term Investments | -- | -- | -- | $16.5M | $21.6M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | $32.5M | $194M | $156.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $192.4M | $237.8M | $377M | $471.9M | $854.5M | |
| Accounts Payable | $4.3M | $2.8M | $4M | $14.8M | $16.6M | |
| Accrued Expenses | $14.4M | $19.6M | $26.1M | $38.3M | $88M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $29K | $308K | $337K | $369K | $402K | |
| Other Current Liabilities | $106K | $243K | $238K | $465K | $417K | |
| Total Current Liabilities | $22.8M | $27.1M | $57.6M | $76.1M | $120.7M | |
| Long-Term Debt | -- | $3.9M | $3.6M | $3.2M | $2.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22.8M | $31M | $76.6M | $84M | $126.9M | |
| Common Stock | $104K | $103K | $105K | $107K | $121K | |
| Other Common Equity Adj | $31K | -$148K | $24K | $14K | $64K | |
| Common Equity | $169.6M | $206.8M | $300.4M | $387.9M | $727.6M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $169.6M | $206.8M | $300.4M | $387.9M | $727.6M | |
| Total Liabilities and Equity | $192.4M | $237.8M | $377M | $471.9M | $854.5M | |
| Cash and Short Terms | $140.3M | $191.3M | $298.4M | $137.6M | $517.6M | |
| Total Debt | -- | $3.9M | $3.6M | $3.2M | $2.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $174.8M | $256.1M | $121M | $442.3M | $689.9M | |
| Short Term Investments | $20M | -- | -- | -- | -- | |
| Accounts Receivable, Net | $6.6M | $9.3M | $48M | $58.3M | $106.4M | |
| Inventory | $7M | $7.1M | $9M | $20M | $28M | |
| Prepaid Expenses | $4M | $3M | $13.6M | $17.9M | $24.2M | |
| Other Current Assets | $228K | $466K | $206K | $509K | -- | |
| Total Current Assets | $192.8M | $276.3M | $192M | $539M | $852.5M | |
| Property Plant And Equipment | $4M | $3.7M | $3.8M | $3.7M | $3.1M | |
| Long-Term Investments | -- | -- | $12.9M | $14.8M | $19.2M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $33.1M | $167.1M | $166M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $223.2M | $333.1M | $413.2M | $772M | $1.1B | |
| Accounts Payable | $2.8M | $2.5M | $4.6M | $11.6M | $9.1M | |
| Accrued Expenses | $14.5M | $21.5M | $34.2M | $82.1M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $278K | $330K | $361K | $393K | -- | |
| Other Current Liabilities | $110K | $237K | $374K | $449K | -- | |
| Total Current Liabilities | $20.6M | $44.7M | $57.8M | $105.4M | $128.7M | |
| Long-Term Debt | $4M | $3.6M | $3.3M | $2.9M | $2.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $24.6M | $63.1M | $64.7M | $111.1M | $131.4M | |
| Common Stock | $103K | $104K | $107K | $119K | $123K | |
| Other Common Equity Adj | -$63K | $32K | $15K | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $198.7M | $270M | $348.5M | $660.9M | $920.2M | |
| Total Liabilities and Equity | $223.2M | $333.1M | $413.2M | $772M | $1.1B | |
| Cash and Short Terms | $174.8M | $256.1M | $121M | $442.3M | $689.9M | |
| Total Debt | $4.3M | $3.6M | $3.3M | $2.9M | $2.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $75M | $39.5M | $83.1M | $71.4M | $163.9M | |
| Depreciation & Amoritzation | $92K | $484K | $1.5M | $33.1M | $38.1M | |
| Stock-Based Compensation | $6.3M | $6.1M | $7.9M | $14.3M | $22.3M | |
| Change in Accounts Receivable | $4.5M | -$632K | -$3.8M | -$43.1M | -$12M | |
| Change in Inventories | -$2.7M | -$3.2M | $1.1M | -$4.7M | -$3.9M | |
| Cash From Operations | $45M | $60.4M | $116M | $143.6M | $239.8M | |
| Capital Expenditures | $11K | $1M | $10M | $198.5M | $556K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5M | -$11M | $9.2M | -$293.5M | -$556K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $12.1M | $6.9M | -- | -- | |
| Other Financing Activities | -$56K | -$153K | -$7.9M | -$13.6M | -$13.6M | |
| Cash From Financing | $702K | -$8.1M | $1.7M | -$10.9M | $140.7M | |
| Beginning Cash (CF) | $89.5M | $171.4M | $298.4M | $137.6M | $517.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $40.7M | $41.2M | $127M | -$160.8M | $379.9M | |
| Ending Cash (CF) | $130.2M | $212.7M | $425.3M | -$23.1M | $897.5M | |
| Levered Free Cash Flow | $45M | $59.4M | $106M | -$54.9M | $239.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $10.3M | $22.7M | -$30.8M | $43.9M | $52.8M | |
| Depreciation & Amoritzation | $139K | $615K | $8.6M | $9.5M | $9.5M | |
| Stock-Based Compensation | $1.5M | $2.1M | $3.8M | $4.4M | $5.7M | |
| Change in Accounts Receivable | -$333K | $250K | -$5.3M | -$1.1M | -$40.5M | |
| Change in Inventories | $147K | $718K | $1.7M | -$2M | -$9.1M | |
| Cash From Operations | $21.7M | $41.3M | $45.1M | $72.9M | $32.4M | |
| Capital Expenditures | $68K | $10M | $64K | $259K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$68K | -$132K | -$92.8M | -$259K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $5.1M | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$10.3M | -$10M | -- | |
| Cash From Financing | -$2.1M | $4M | -$10.1M | -$6M | $4.7M | |
| Beginning Cash (CF) | $154.8M | $256.1M | $121M | $442.3M | $689.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.5M | $45.2M | -$57.8M | $66.6M | $37.1M | |
| Ending Cash (CF) | $174.4M | $301.2M | $63.2M | $509M | $727M | |
| Levered Free Cash Flow | $21.6M | $31.3M | $45.1M | $72.6M | $32.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $41.6M | $66.9M | $62M | $142.8M | $217.6M | |
| Depreciation & Amoritzation | $406.5K | $917K | $24.6M | $37.7M | $38.1M | |
| Stock-Based Compensation | $6.1M | $7.5M | $11.9M | $21.3M | $24.3M | |
| Change in Accounts Receivable | -$753.5K | -$2.7M | -$38.7M | -$10.2M | -$48.1M | |
| Change in Inventories | -$2.2M | -$182K | $2.2M | -$11M | -$8.4M | |
| Cash From Operations | $54.3M | $95.1M | $128M | $224.6M | $234.7M | |
| Capital Expenditures | $980K | $10.1M | $162.4M | $36.6M | $114K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$11M | $9.2M | -$255.2M | -$38.8M | -$114K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $9M | $10M | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$20.1M | -$13.4M | -- | |
| Cash From Financing | -$5.6M | -$3.1M | -$7.9M | $135.6M | $13M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $37.7M | $101.2M | -$135.1M | $321.4M | $247.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $53.3M | $85.1M | -$34.4M | $188M | $234.5M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $30.2M | $57.6M | $36.6M | $108M | $161.6M | |
| Depreciation & Amoritzation | $267K | $808K | $23.9M | $28.5M | $28.6M | |
| Stock-Based Compensation | $4.6M | $6M | $10M | $17.1M | $19.1M | |
| Change in Accounts Receivable | -$638K | -$2.7M | -$37.6M | -$4.8M | -$40.9M | |
| Change in Inventories | -$2.3M | $738K | $1.9M | -$4.4M | -$8.9M | |
| Cash From Operations | $41.2M | $76M | $88M | $168.9M | $163.8M | |
| Capital Expenditures | $980K | $10M | $162.4M | $468K | $26K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$11M | $9.2M | -$255.2M | -$468K | -$26K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $1.1M | $6.9M | -- | -- | -- | |
| Other Financing Activities | -$17K | -$20K | -$12.3M | -$12M | -$3.1M | |
| Cash From Financing | -$5.6M | -$559K | -$10.2M | $136.2M | $8.6M | |
| Beginning Cash (CF) | $412.4M | $645.3M | $448M | $1.1B | $1.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $24.6M | $84.6M | -$177.4M | $304.7M | $172.3M | |
| Ending Cash (CF) | $437M | $730M | $270.6M | $1.4B | $2.1B | |
| Levered Free Cash Flow | $40.2M | $65.9M | -$74.5M | $168.5M | $163.8M | |
Get CPRX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CPRX
Sector
P/E ratio
14.27x
23.89x
PEG ratio
0.31x
-0.01x
P/B ratio
3.27x
1.81x
Price / LTM sales
5.37x
1.59x
Growth Metrics
CPRX
Sector
Revenue growth
15.31%
4.62%
Earnings growth
18.69%
11.06%
Revenue (5-year growth)
36.89%
6.5%
Earnings forecast
$0.54
-$0.21
Profitability
CPRX
Sector
Profitability FY 2024
$385.5M
$3.6M
Return on invested capital
27.37%
-31.84%
Return on assets
23.86%
-27.96%
Return on equity
27.48%
-37.63%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
4
Balance Sheet
CPRX
Sector
Total cash
$689.9M
$26.4M
Short term investments
--
$25.7M
Total assets
$854.5M
$76.9M
Long term debt
$2.5M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
